Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)

Clinical trial NCT00212004 · TERMINATED

Trial details

NCT number: NCT00212004
Sponsor: National Cerebral and Cardiovascular Center, Japan
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus Myocardial Infarction

Start date: 2005-04-01
Primary completion: 2017-04-01
Enrollment: 630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.